Glycolipids from Sponges
Journal of Natural Products, 2006, Vol. 69, No. 1 77
affording a fraction (50.9 mg) containing peracetylated clathrosides and
isoclathrosides, together with larger amounts of other peracetylated
glycolipids. Further normal-phase HPLC purification of these fractions
[eluent: n-hexane/i-PrOH (97:3)] gave 4.9 mg of a mixture of
peracetylated clathrosides A-C (2b-4b) and 4.3 mg of a mixture of
peracetylated isoclathrosides A-C (5b-7b). Reversed-phase HPLC
separation of the former fraction on an RP-18 column [eluent: MeOH/
H2O (97:3)] gave 1.2 mg of pure clathroside A peracetate (2b) and 1.8
mg of an inseparable mixture of clathroside B peracetate (3b) and
clathroside C peracetate (4b). Likewise, reversed-phase HPLC separa-
tion of the latter fraction under the same conditions gave 0.9 mg of
pure isoclathroside A peracetate (5b) and 1.2 mg of an inseparable
mixture of isoclathroside B peracetate (6b) and isoclathroside C
peracetate (7b).
chains), 28.2 (CH2, C-4), 26.1 (CH2, C-4′), 23.0 (CH2, C-15 and C-15′),
14.3 (CH3, C-16 and C-16′); HRESIMS m/z 665.5312 ([M + Na]+,
calcd for C38H74NaO7 665.5327).
Mixture of isoclathroside B (6a) and isoclathroside C (7a):
1
colorless oil; H NMR (500 MHz, pyridine-d5), same spectrum as 5a,
except for the methyl region, δ 0.86 (6H, m); HRESIMS m/z 679.5505
([M + Na]+, calcd for C39H76NaO7 679.5483).
Oxidative Cleavage of Clathroside A (2a) and Isoclathroside A
(5a). Compound 2a (100 µg) was subjected to oxidative cleavage with
KMnO4/NaIO4 as described,8 and the resulting carboxylic acids were
methylated with CH2N2. After removal of the solvent, the residue was
analyzed by GC-MS and shown to be composed only of methyl
pentadecanoate (tR ) 15.08), identified by comparison of its retention
time and mass spectrum with those of an authentic sample. Oxidation
of isoclathroside A (5a) gave the same results.
Clathroside A peracetate (2b): colorless oil, [R]D25 -9 (CHCl3, c
1
0.1); H and 13C NMR, Table 1.
Oxidative Cleavage of Clathrosides B (3a) and C (4a). A small
portion of the mixture of compounds 3a and 4a (100 µg) was subjected
to oxidative cleavage with KMnO4/NaIO4 as described above. GC-MS
analysis of the resulting methyl esters mixture showed it to be composed
of methyl pentadecanoate (tR ) 15.08, 49.8%), methyl 14-methylpen-
tadecanoate (tR ) 17.10, 9.5%), and methyl 13-methylpentadecanoate
(tR ) 17.34, 40.7%). All the esters were identified by comparison of
its retention time and mass spectrum with those of an authentic sample.
Oxidative Cleavage of Isoclathrosides B (6a) and C (7a). A small
portion of the mixture of compounds 6a and 7a (100 µg) was subjected
to oxidative cleavage with KMnO4/NaIO4 as described above. GC-MS
analysis of the resulting methyl esters mixture showed it to be composed
of methyl pentadecanoate (tR ) 15.12, 53.4%), methyl 14-methylpen-
tadecanoate (tR ) 17.15, 9.7%), and methyl 13-methylpentadecanoate
(tR ) 17.39, 36.9%).
Clathroside A Perbenzoate (2d). Clathroside A (2a, 400 µg) was
benzoylated with benzoyl chloride (10 µL) in pyridine (200 µL) at 25
°C for 16 h. The reaction was then quenched with MeOH and after 30
min was dried under nitrogen. Methyl benzoate was removed by keeping
the residue under vacuum for 24 h with an oil pump, and the crude
reaction product was purified by HPLC (column: Luna SiO2, 5 µ;
eluent: n-hexane/i-PrOH (99:1), flow 1 mL/min, λ 280 nm), giving
pure clathroside A perbenzoate (2d): 1H NMR (CDCl3) δ 8.03 (2H, d,
J ) 7.8 Hz, benzoyl o-protons), 7.99 (4H, d, J ) 7.8 Hz, benzoyl
o-protons), 7.87 (2H, d, J ) 7.8 Hz, benzoyl o-protons), 7.82 (2H, d,
J ) 7.8 Hz, benzoyl o-protons), 7.57-7.26 (15H, m, benzoyl protons),
5.85 (1H, t, J ) 9.7 Hz, H-3′′), 5.66-5.53 (3H, m, H-2′, H-2′′, and
H-4′′), 5.39 (1H, br d, J ) 9.0 Hz, H-1′), 4.80 (1H, d, J ) 7.9 Hz,
H-1′′), 4.47 (1H, dd, J ) 12.2 and 3.0 Hz, H-6′′a), 4.35 (1H, dd, J )
12.2 and 5.6 Hz, H-6′′b), 4.29 (1H, br d, J ) 12.4 Hz, H-1a), 4.08
(1H, br d, J ) 12.4 Hz, H-1b), 3.90 (1H, m, H-5′′), 2.11 (1H, m, H-3a),
1.92 (1H, m, H-3b), 1.70 (1H, m, H-3′a), 1.49 (1H, m, H-3′b).
Isoclathroside A perbenzoate (5d) was prepared as described
above: 1H NMR (CDCl3) δ 8.04 (2H, d, J ) 7.8 Hz, benzoyl o-protons),
7.99 (2H, d, J ) 7.8 Hz, benzoyl o-protons), 7.94 (4H, d, J ) 7.8 Hz,
benzoyl o-protons), 7.90 (2H, d, J ) 7.8 Hz, benzoyl o-protons), 7.82
(2H, d, J ) 7.8 Hz, benzoyl o-protons), 7.60-7.26 (15H, benzoyl
protons), 5.91 (1H, t, J ) 9.7, H-3′′), 5.68 (1H, t, J ) 9.7 Hz, H-4′′),
5.56 (1H, dd, J ) 9.7 and 8.0 Hz, H-2′′), 5.53 (1H, m, H-2′), 5.31
(1H, br d, J ) 9.3 Hz, H-1′), 4.94 (1H, d, J ) 8.1 Hz, H-1′′), 4.72
(1H, dd, J ) 12.2 and 2.8 Hz, H-6′′a), 4.69 (1H, br d, J ) 12.9 Hz,
H-1a), 4.52 (1H, dd, J ) 12.2 and 5.2 Hz, H-6′′b), 4.45 (1H, m, H-5′′),
4.18 (1H, br d, J ) 12.9 Hz, H-1b), 1.91 (1H, m, H-3a), 1.75 (1H, m,
H-3b), 1.65 (1H, m, H-3′a), 1.50 (1H, m, H-3′b).
Mixture of clathroside B peracetate (3b) and clathroside C
peracetate (4b): colorless oil; 1H NMR (500 MHz, CDCl3), same
spectrum as 2b, except for the methyl region, δ 0.88 (3b and 4b, t, J
) 7.0 Hz, H3-16), 0.86 (4b, d, J ) 6.6 Hz, H3-16′ and H3-17′), 0.85
(3b, t, J ) 7.2 Hz, H3-16′), 0.84 (3b, d, J ) 6.5 Hz, H3-17′); 13C NMR
(CDCl3), same signals as for 2b, plus δ 39.1 (4b, CH2, C-14′), 36.6
(3b, CH2, C-13′), 34.4 (3b, CH, C-14′), 27.1 (3b, CH2, C-12′), 22.7
(4b, CH3, C-16′ and C-17′), 19.2 (3b, CH3, C-17′), 11.4 (3b, CH3,
C-16′).
Isoclathroside A peracetate (5b): colorless oil; [R]D25 -12 (CHCl3,
1
c 0.1); H and 13C NMR, Table 1.
Mixture of isoclathroside B peracetate (6b) and isoclathroside
1
C peracetate (7b): colorless oil; H NMR (500 MHz, CDCl3), same
spectrum as 5b, except for the methyl region, which was the same as
in 3b-4b; 13C NMR (CDCl3), same signals as 5b, plus the same
additional signals as in 3b-4b.
Deacetylation of 2b-7b. Compound 2b (1.2 mg) was dissolved in
950 µL of MeOH, and 50 µL of a 0.4 M solution of MeONa in MeOH
was added. The reaction was allowed to proceed for 18 h at 25 °C,
then the reaction mixture was dried under nitrogen and the residue
partitioned between H2O and CHCl3. The organic layer was washed
with H2O and taken to dryness, giving 1.0 mg of clathroside A (2a).
Compounds 3b-7b were deacetylated using the same procedure.
Clathroside A (2a): colorless oil; [R]D25 -6 (CHCl3, c 0.1); 1H NMR
(500 MHz, pyridine-d5) δ 7.28 (1H, d, J ) 4.4 Hz, OH-2′′), 7.16 (1H,
d, J ) 3.0 Hz, OH-3′′), 7.14 (1H, d, J ) 4.0 Hz, OH-4′′), 6.41 (1H, t,
J ) 6.3 Hz, OH-6′′), 6.15 (1H, d, J ) 4.2 Hz, OH-2′), 6.08 (1H, br d,
J ) 8.9 Hz, H-1′), 4.98 (1H, d, J ) 7.8 Hz, H-1′′), 4.83 (1H, m, H-2′),
4.70 (1H, br d, J ) 12.3 Hz, H-1a), 4.57 (1H, m, H-6′′a), 4.40 (2H, m,
H-6′′b and H-1b), 4.25 (2H, m, H-3′′ and H-4′′), 4.11 (1H, m, H-2′′),
3.95 (1H, m, H-5′′), 2.43 (1H, m, H-3a), 2.37 (1H, m, H-3b), 1.92
(1H, m, H-3′a), 1.63 (1H, m, H-3′b), 1.59 (1H, m, H-4a), 1.49 (1H, m,
H-4b), 1.33-1.20 (alkyl chain protons), 0.86 (3H, t, J ) 6.8 Hz, H3-
16 and H3-16′); 13C NMR (pyridine-d5) δ 137.1 (C, C-2), 132.9 (CH,
C-1′), 103.7 (CH, C-1′′), 78.7 (CH, C-3′′), 78.5 (CH, C-5′′), 75.3 (CH,
C-2′′), 72.7 (CH2, C-1), 71.9 (CH, C-4′′), 67.4 (CH, C-2′), 62.9 (CH2,
C-6′′), 38.9 (CH2, C-3′), 32.2 (CH2, C-14 and C-14′), 30.2-29.7 (several
CH2, alkyl chains), 29.1 (CH2, C-4), 28.9 (CH2, C-3), 26.3 (CH2, C-4′),
23.0 (CH2, C-15 and C-15′), 14.3 (CH3, C-16 and C-16′); HRESIMS
m/z 665.5352 ([M + Na]+, calcd for C38H74NaO7 665.5327).
Mixture of clathroside B (3a) and clathroside C (3a): colorless
oil; 1H NMR (500 MHz, pyridine-d5), same spectrum as 2a, except for
the methyl region, δ 0.86 (6H, m); HRESIMS m/z 679.5500 ([M +
Na]+, calcd for C39H76NaO7 679.5483).
Clathroside A 2′-O-benzoate (2e). Compound 2d was subjected to
basic methanolysis by keeping it in 0.5 mL of MeOH/Et3N (8:2) at 55
°C for 18 h. Removal of the solvent and HPLC purification (column:
SiO2, eluent: n-hexane/i-PrOH (85:15), flow 1 mL/min, λ 280 nm)
gave pure compound 2e: CD (MeOH) λmax ) 227 nm (∆ꢀ ) +5.1);
1H NMR (CDCl3) δ 8.03 (2H, br d, J ) 7.8 Hz, benzoyl o-protons),
7.55 (1H, br t, J ) 7.5 Hz, benzoyl p-proton), 7.43 (2H, t, J ) 7.6 Hz,
benzoyl m-protons), 5.73 (1H, m, H-2′), 5.51 (1H, br d, J ) 9.2 Hz,
H-1′), 4.27-4.35 (2H, m, H-1a and H-1′′), 4.04 (1H, br d, J ) 12.9
Hz, H-1b), 3.85 (1H, dd, J ) 12.0 and 3.3 Hz, H-6′′a), 3.75 (1H, dd,
J ) 12.0 and 5.1 Hz, H-6′′b), 3.60-3.47 (2H, m, H-3′′ and H-4′′),
3.38 (1H, t, J ) 8.7 Hz, H-2′′), 3.30 (1H, m, H-5′′).
25
1
Isoclathroside A (5a): colorless oil; [R]D -2 (CHCl3, c 0.1); H
NMR (700 MHz, pyridine-d5) δ 7.26 (1H, d, J ) 3.6 Hz, OH-2′′),
7.18 (1H, br s, OH-3′′ or OH-4′′), 7.11 (1H, br s, OH-4′′ or OH-3′′),
6.53 (1H, t, J ) 5.4 Hz, OH-6′′), 6.06 (1H, d, J ) 4.2 Hz, OH-2′),
5.87 (1H, br d, J ) 8.6 Hz, H-1′), 4.99 (1H, d, J ) 7.8 Hz, H-1′′), 4.97
(1H, m, H-2′), 4.85 (1H, br d, J ) 11.8 Hz, H-1a), 4.62 (br d, J ) 11.8
Hz, H-1b), 4.60 (overlapped, H-6′′a), 4.37 (1H, ddd, J ) 11.6, 5.9,
and 5.9 Hz, H-6′′b), 4.20 (2H, overlapped, H-3′′ and H-4′′), 4.10 (1H,
m, H-2′′), 4.01 (1H, m, H-5′′), 2.50 (1H, m, H-3a), 2.30 (1H, m, H-3b),
1.91 (1H, m, H-3′a), 1.71 (1H, m, H-3′b), 1.55 (2H, m, H2-4), 1.33-
1.20 (alkyl chain protons), 0.86 (3H, t, J ) 6.8 Hz, H3-16 and H3-16′);
13C NMR (pyridine-d5) δ 135.5 (CH, C-1′), 102.5 (CH, C-1′′), 78.7
(CH, C-3′′), 78.4 (CH, C-5′′), 75.2 (CH, C-2′′), 71.9 (CH, C-4′′), 67.4
(CH, C-2′), 65.6 (CH2, C-1), 62.9 (CH2, C-6′′), 39.1 (CH2, C-3′), 35.1
(CH2, C-3), 32.2 (CH2, C-14 and C-14′), 30.2-29.7 (several CH2, alkyl
Isoclathroside A 2′-O-benzoate (5e) was prepared as described
1
above: CD (MeOH) λmax ) 228 nm (∆ꢀ ) -5.5); H NMR (CDCl3)
δ 8.02 (2H, br d, J ) 7.8 Hz, benzoyl o-protons), 7.55 (1H, br t, J )
7.6 Hz, benzoyl p-proton), 7.43 (2H, br t, J ) 7.8 Hz, benzoyl